Purpose: Hepatic artery infusion of Yittrium-90 microspheres (Therasphere™) is a promising
technique for treating hepatic malignancies. Compared with external beam therapy, this …

Background Sorafenib is the recommended treatment for patients with advanced
hepatocellular carcinoma. We aimed to compare the efficacy and safety of sorafenib to that …

Hepatocellular carcinoma (HCC) and intrahepatic cholangiocarcinoma (ICC) often present
at stages where patients have limited treatment options. Use of selective internal radiation …

Hepatocellular carcinoma (HCC) is one of the most malignant tumors, the morbidity and
mortality of HCC ranked 6th and 3rd among all malignant tumors, respectively. Patients with …

Purpose: To evaluate the efficacy of intraarterial 90yttrium (90Y) microspheres in
nonresectable hepatocellular carcinoma (HCC). Methods and Materials: Patients with …

Purpose To present the clinical data of 35 patients with T3 unresectable hepatocellular
carcinoma (HCC) that were treated with 90Y with the specific intent of downstaging to …

90 Y radioembolization refers to the selective, transcatheter, and intra-arterial injection of
micrometer-sized particles loaded with the radioisotope yttrium-90 for the treatment of …

Purpose To evaluate outcomes of yttrium-90 radioembolization performed with glass-based
microspheres in the treatment of hepatocellular carcinoma (HCC) secondary to the hepatitis …

PURPOSE: Selective internal radiotherapy (SIRT) with yttrium-90 (90Y) resin microspheres
can improve the clinical outcomes for selected patients with inoperable liver cancer. This …